These results illustrated that CPT treatment inhibits inflammatory response and regulates microglia polarization via activating AKT/Nrf2/HO-1 and inhibiting NF-κB pathways in LPS- injected PD mouse model. This evidence concerns the gene NFKB1 and Parkinson disease.